Patent 7915253 was granted and assigned to KALYPSYS, INC. on March, 2011 by the United States Patent and Trademark Office.
Compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.